Neurogenic Hypertension: Revelations from Genome-Wide Gene Expression Profiling (original) (raw)

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of outstanding importance

  1. •• Ehret GB, Munroe PB, Rice KM, et al.: Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011, 478:103–109. This was the largest meta-analysis, combining genome-wide association studies for blood pressure and essential hypertension.
    Article CAS PubMed Google Scholar
  2. Coffman TM. Under pressure: the search for the essential mechanisms of hypertension. Nat Med. 2011;17:1402–9.
    Article CAS PubMed Google Scholar
  3. Grassi G, Seravalle G, Quarti-Trevano F. The ‘neuroadrenergic hypothesis’ in hypertension: current evidence. Exp Physiol. 2010;95:581–6.
    Article PubMed Google Scholar
  4. • Fisher JP, Paton JF: The sympathetic nervous system and blood pressure in humans: implications for hypertension. J Hum Hypertens 2011: in press. This paper is a concise review of the role of the sympathetic nervous system in hypertension.
  5. Davern PJ, Nguyen-Huu TP, La Greca L, et al. Role of the sympathetic nervous system in Schlager genetically hypertensive mice. Hypertension. 2009;54:852–9.
    Article CAS PubMed Google Scholar
  6. Davern PJ, Jackson KL, Nguyen-Huu TP, et al. Cardiovascular responses to aversive and non-aversive stressors in Schlager genetically hypertensive mice. Am J Hypertens. 2010;23:838–44.
    Article PubMed Google Scholar
  7. Davern PJ, Jackson KL, Nguyen-Huu TP, et al. Cardiovascular reactivity and neuronal activation to stress in Schlager genetically hypertensive mice. Neuroscience. 2010;170:551–8.
    Article CAS PubMed Google Scholar
  8. Palma-Rigo K, Jackson KL, Davern PJ, et al. Renin-angiotensin and sympathetic nervous system contribution to high blood pressure in Schlager mice. J Hypertens. 2011;29:2156–66.
    Article CAS PubMed Google Scholar
  9. Dampney RA, Horiuchi J, Killinger S, et al. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Pharmacol Physiol. 2005;32:419–25.
    Article CAS PubMed Google Scholar
  10. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335–46.
    Article CAS PubMed Google Scholar
  11. Davern PJ, Head GA. Role of the medial amygdala in mediating responses to aversive stimuli leading to hypertension. Clin Exp Pharmacol Physiol. 2011;38:136–43.
    Article CAS PubMed Google Scholar
  12. •• Marques FZ, Campain AE, Davern PJ, et al.: Global identification of the genes and pathways differentially expressed in hypothalamus in early and established neurogenic hypertension. Physiol Genomics 2011,43:766–771. This paper describes all the genes differentially expressed in the hypothalamus during the development and maintenance phases of hypertension in a mouse model of neurogenic hypertension.
    Article CAS PubMed Google Scholar
  13. Jaffrey SR, Snyder SH. PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science. 1996;274:774–7.
    Article CAS PubMed Google Scholar
  14. Fan JS, Zhang Q, Li M, et al. Protein inhibitor of neuronal nitric-oxide synthase, PIN, binds to a 17-amino acid residue fragment of the enzyme. J Biol Chem. 1998;273:33472–81.
    Article CAS PubMed Google Scholar
  15. Lalor SJ, Segal BM. Lymphoid chemokines in the CNS. J Neuroimmunol. 2010;224:56–61.
    Article CAS PubMed Google Scholar
  16. •• Marques FZ, Campain AE, Yang YH, Morris BJ: Meta-analysis of genome-wide gene expression differences in onset and maintenance phases of genetic hypertension. Hypertension 2010,56:319–324. This paper identifies genes that are differentially expressed during the waking surge of blood pressure, well known to be a risk factor for cardiovascular events.
    Article CAS PubMed Google Scholar
  17. Marques FZ, Campain AE, Davern PJ, et al. Genes influencing circadian differences in blood pressure in hypertensive mice. PLoS One. 2011;6:e19203.
    Article CAS PubMed Google Scholar
  18. Pravenec M, Kurtz TW. Recent advances in genetics of the spontaneously hypertensive rat. Curr Hypertens Rep. 2010;12:5–9.
    Article PubMed Google Scholar
  19. Okamoto K, Nosaka S, Yamori Y, Matsumoto M. Participation of neural factor in the pathogenesis of hypertension in the spontaneously hypertensive rat. Jpn Heart J. 1967;8:168–80.
    Article CAS PubMed Google Scholar
  20. Iriuchijima J. Sympathetic discharge rate in spontaneously hypertensive rats. Jpn Heart J. 1973;14:350–6.
    Article CAS PubMed Google Scholar
  21. Judy WV, Watanabe AM, Henry DP, et al. Sympathetic nerve activity: role in regulation of blood pressure in the spontaneously hypertensive rat. Circ Res. 1976;38:21–9.
    Article CAS PubMed Google Scholar
  22. Collis MG, de May C, Vanhoutte PM. Enhanced release of noradrenaline in the kidney of the young spontaneously hypertensive rat. Clin Sci (Lond). 1979;57 Suppl 5:233s–4.
    Google Scholar
  23. Collis MG, DeMey C, Vanhoutte PM. Renal vascular reactivity in the young spontaneously hypertensive rat. Hypertension. 1980;2:45–52.
    Article CAS PubMed Google Scholar
  24. Winternitz SR, Katholi RE, Oparil S. Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest. 1980;66:971–8.
    Article CAS PubMed Google Scholar
  25. Allen AM. Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone. Hypertension. 2002;39:275–80.
    Article CAS PubMed Google Scholar
  26. Reja V, Goodchild AK, Phillips JK, Pilowsky PM. Upregulation of angiotensin AT1 receptor and intracellular kinase gene expression in hypertensive rats. Clin Exp Pharmacol Physiol. 2006;33:690–5.
    Article CAS PubMed Google Scholar
  27. Waki H, Gouraud SS, Maeda M, et al. Contributions of vascular inflammation in the brainstem for neurogenic hypertension. Respir Physiol Neurobiol. 2011;178:422–8.
    Article CAS PubMed Google Scholar
  28. Waki H, Liu B, Miyake M, et al. Junctional adhesion molecule-1 is upregulated in spontaneously hypertensive rats: evidence for a prohypertensive role within the brain stem. Hypertension. 2007;49:1321–7.
    Article CAS PubMed Google Scholar
  29. Waki H, Gouraud SS, Maeda M, Paton JF. Evidence of specific inflammatory condition in nucleus tractus solitarii of spontaneously hypertensive rats. Exp Physiol. 2010;95:595–600.
    Article CAS PubMed Google Scholar
  30. Ferrari MF, Reis EM, Matsumoto JP, Fior-Chadi DR. Gene expression profiling of cultured cells from brainstem of newborn spontaneously hypertensive and Wistar Kyoto rats. Cell Mol Neurobiol. 2009;29:287–308.
    Article CAS PubMed Google Scholar
  31. Li Y, Zhang W, Stern JE. Nitric oxide inhibits the firing activity of hypothalamic paraventricular neurons that innervate the medulla oblongata: role of GABA. Neuroscience. 2003;118:585–601.
    Article CAS PubMed Google Scholar
  32. Rossi NF, Maliszewska-Scislo M, Chen H, et al. Neuronal nitric oxide synthase within paraventricular nucleus: blood pressure and baroreflex in two-kidney, one-clip hypertensive rats. Exp Physiol. 2010;95:845–57.
    Article CAS PubMed Google Scholar
  33. Shi P, Diez-Freire C, Jun JY, et al. Brain microglial cytokines in neurogenic hypertension. Hypertension. 2010;56:297–303.
    Article CAS PubMed Google Scholar
  34. Harrison DG, Guzik TJ, Lob HE, et al. Inflammation, immunity, and hypertension. Hypertension. 2011;57:132–40.
    Article CAS PubMed Google Scholar
  35. Datla SR, Griendling KK. Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension. 2010;56:325–30.
    Article CAS PubMed Google Scholar
  36. Shokoji T, Nishiyama A, Fujisawa Y, et al. Renal sympathetic nerve responses to Tempol in spontaneously hypertensive rats. Hypertension. 2003;41:266–73.
    Article CAS PubMed Google Scholar
  37. Lob HE, Marvar PJ, Guzik TJ, et al. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension. 2010;55:277–83.
    Article CAS PubMed Google Scholar
  38. Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am. 2009;93:621–35.
    Article CAS PubMed Google Scholar
  39. Marvar PJ, Lob H, Vinh A, et al. The central nervous system and inflammation in hypertension. Curr Opin Pharmacol. 2011;11:156–61.
    Article CAS PubMed Google Scholar
  40. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677–87.
    Article CAS PubMed Google Scholar
  41. Lee C, Scherer SW. The clinical context of copy number variation in the human genome. Expert Rev Mol Med. 2010;12:e8.
    Article PubMed Google Scholar
  42. Craddock N, Hurles ME, Cardin N, et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature. 2010;464:713–20.
    Article CAS PubMed Google Scholar
  43. Charchar FJ, Kaiser M, Bingham AJ, et al. Whole genome survey of copy number variation in the spontaneously hypertensive rat: relationship to quantitative trait loci, gene expression, and blood pressure. Hypertension. 2010;55:1231–8.
    Article CAS PubMed Google Scholar
  44. Batkai S, Thum T. MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep. 2012;14:79–87.
    Article CAS PubMed Google Scholar
  45. Wang X, Snieder H. Genome-wide association studies and beyond: what’s next in blood pressure genetics? Hypertension. 2010;56:1035–7.
    Article CAS PubMed Google Scholar
  46. • Huntzinger E, Izaurralde E: Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011,12:99–110. This is a good review describing how microRNAs regulate mRNA levels.
    Article CAS PubMed Google Scholar
  47. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011;469:336–42.
    Article CAS PubMed Google Scholar
  48. Latronico MV, Condorelli G. microRNAs in hypertrophy and heart failure. Exp Biol Med (Maywood). 2011;236:125–31.
    Article CAS Google Scholar
  49. Qin S, Zhang C. microRNAs in vascular disease. J Cardiovasc Pharmacol. 2011;57:8–12.
    Article CAS PubMed Google Scholar
  50. Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther. 2011;25:171–82.
    Article CAS PubMed Google Scholar
  51. Elton TS, Martin MM, Sansom SE, et al. miRNAs got rhythm. Life Sci. 2011;88:373–83.
    Article CAS PubMed Google Scholar
  52. Hansen KF, Sakamoto K, Obrietan K. microRNAs: a potential interface between the circadian clock and human health. Genome Med. 2011;3:10.
    Article CAS PubMed Google Scholar
  53. Sethupathy P, Borel C, Gagnebin M, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet. 2007;81:405–13.
    Article CAS PubMed Google Scholar
  54. Ceolotto G, Papparella I, Bortoluzzi A, et al. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens. 2011;24:241–6.
    Article CAS PubMed Google Scholar
  55. Fan ZD, Zhang L, Shi Z, et al.: Artificial microRNA interference targeting AT(1a) receptors in paraventricular nucleus attenuates hypertension in rats. Gene Ther 2011
  56. •• Marques FZ, Campain AE, Tomaszewski M, et al.: Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 2011,58:1093–1098. This genome-wide study identified the genes and microRNAs that were differentially expressed in human hypertensive kidneys; it also showed how two microRNAs are able to regulate renin mRNA, so a reduction in these could explain why levels of renin mRNA were higher.
    Article CAS PubMed Google Scholar
  57. •• Schlaich MP, Sobotka PA, Krum H, et al.: Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009,361:932–934. This paper showed that renal sympathetic denervation is an effective treatment for uncontrolled hypertension.
    Article CAS PubMed Google Scholar
  58. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861–74.
    Article CAS PubMed Google Scholar
  59. Paralkar VR, Weiss MJ. A new ‘Linc’ between noncoding RNAs and blood development. Genes Dev. 2011;25:2555–8.
    Article CAS PubMed Google Scholar
  60. Pauli A, Rinn JL, Schier AF. Non-coding RNAs as regulators of embryogenesis. Nat Rev Genet. 2011;12:136–49.
    Article CAS PubMed Google Scholar
  61. Ng SY, Johnson R, Stanton LW. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J. 2012;31:522–33.
    Article CAS Google Scholar
  62. Niland CN, Merry CR, Khalil AM. Emerging roles for long non-coding RNAs in cancer and neurological disorders. Front Genet. 2012;3:25.
    PubMed Google Scholar
  63. •• Cabili MN, Trapnell C, Goff L, et al.: Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011,25:1915–1927. This paper describes all of the long intergenic non-coding RNAs in humans.
    Article CAS PubMed Google Scholar
  64. Millis RM. Epigenetics and hypertension. Curr Hypertens Rep. 2011;13:21–8.
    Article CAS PubMed Google Scholar
  65. Esler M, Eikelis N, Schlaich M, et al. Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder. Ann N Y Acad Sci. 2008;1148:338–48.
    Article CAS PubMed Google Scholar
  66. Guan J, Mao C, Xu F, et al. Prenatal dehydration alters renin-angiotensin system associated with angiotensin-increased blood pressure in young offspring. Hypertens Res. 2009;32:1104–11.
    Article CAS PubMed Google Scholar
  67. Riviere G, Lienhard D, Andrieu T, et al. Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics. 2011;6:478–89.
    Article CAS PubMed Google Scholar
  68. Lee HA, Cho HM, Lee DY, et al. Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications. Hypertension. 2012;59:621–6.
    Article CAS PubMed Google Scholar
  69. • Moreno C, Hoffman M, Stodola TJ, et al.: Creation and characterization of a renin knockout rat. Hypertension 2011,57:614–619. This paper was the first to make use of zinc finger nuclease technology to generate a knockout animal.
    Article CAS PubMed Google Scholar
  70. Premsrirut PK, Dow LE, Kim SY, et al. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell. 2011;145:145–58.
    Article CAS PubMed Google Scholar
  71. Hudson TJ, Anderson W, Artez A, et al. International network of cancer genome projects. Nature. 2010;464:993–8.
    Article CAS PubMed Google Scholar

Download references